Objective. To examine anti-double-stranded DNA (anti-dsDNA) IgG autoantibodies from the bone marrow of individuals with systemic lupus erythematosus (SLE).Methods. A library of single-chain variable fragments (scFv) was constructed from SLE bone marrow complementary DNA of ␥, , and isotype by cloning into the pHENIX phagemid vector. The library was screened with dsDNA in solution, and 2 anti-DNA phage, DNA1 and DNA4, were isolated and their Ig V genes sequenced. Soluble scFv corresponding to DNA1 and DNA4, and their heavy (H)-and light (L)-chain recombinants, were prepared, purified, and analyzed for binding to DNA by enzyme-linked immunosorbent assay.Results. DNA1 and DNA4 used different Ig H-chain (3-30 and 5-51, respectively) and L-chain (DPK15 and DPK22, respectively) V genes. The ratios of replacement mutations to silent mutations in DNA1 and DNA4 suggest that their V genes were selected for improved antigen binding in vivo. The recombinant between DNA4VH and DNA1VL showed the highest relative affinity for both single-stranded DNA and dsDNA. These 2 Ig subunits contained third complementarity-determining region arginines and had acquired the majority of replacement mutations.Conclusion. Anti-dsDNA IgG autoantibodies from the bone marrow of SLE patients exploit diverse V genes and cationic V-D-J and V-J junctions for DNA binding, and accumulate replacement mutations that enhance binding.Anti-double-stranded DNA (anti-dsDNA) antibodies represent an important specificity among the diverse autoantibodies that are found in systemic lupus erythematosus (SLE), yet their molecular characterization remains incomplete (for review, see ref. 1). AntidsDNA IgG autoantibodies use a variety of recurrent heavy (H)-and light (L)-chain V-region (V H and V L ) genes, and anti-dsDNA-combining sites often acquire somatic replacement mutations during the process of clonal expansion (2,3). Frequently, these replacement mutations generate arginine, asparagine, or lysine side chains whose functional groups are suitable for contacts with DNA. These replacement mutations, and the arginine residues found in the third complementaritydetermining region (CDR3) of many anti-DNA H and L chains, are consistent with positive selection of antidsDNA autoantibodies for improved binding to DNA. Selection for DNA binding was demonstrated in murine anti-dsDNA autoantibodies by reversion of somatic replacement mutations and by in vitro mutagenesis of arginines at the V-D-J junction (4,5).The detailed characterization of anti-dsDNA V genes has been further advanced by the expression of antibody fragments on the surface of bacteriophage (3,6). This heterologous expression system affords the opportunity to screen a large, highly diverse crosssection of the V-gene repertoire.